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ABSTRACT
Background Oxytocin is widely used in perinatal 
medicine, but it can cause serious side effects. Health 
professionals should be familiar with the pharmacoki-
netics, dosing regimen, and fetal effects of oxytocin. 
This study aims to explore the use of oxytocin by 
healthcare professionals during labor.
Methods This study was conducted in one medical 
faculty, one training and research hospital, one mater-
nity hospital, and one private hospital in Adana, Turkey. 
The sample group included 107 participants. The data 
were gathered using a survey prepared in line with the 
literature. The survey was comprised of 30 questions. 
These questions concern the social demographic infor-
mation of the participants, the knowledge and actual 
oxytocin use, and the views of the participants. The data 
were analyzed using descriptive statistics.
Results The average age of the participants was 36.76 
± 8.70 years, the mean of working experience in the 
delivery room was 7.79 ± 7.73 years. 85.6% of the par-
ticipants who answered the question of possible effects 
of oxytocin as contraction, 57.9% of the possible side 
effects as fetal distress. 69.2% of the participants stated 
that they applied oxytocin after dilution in a fluid while 
47% stated that they applied it after dilution in fluid with 
5% Dextrose. While 40% of the participants responded 
that they sometimes forgot to administer medication, 
39.2% stated that they did not register medication in 
their survey responses.
Conclusion It was determined that most of the 
participants answered the questions about the effect of 
oxytocin correctly, but they could not respond to all the 
side effects of oxytocin. It was found that most of the 
participants could not answer the storage conditions that 
are important for the effectiveness of the drug correctly. 
In addition, the importance level given to the principles 
of drug administration by the participants was generally 
found to be high.
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Synthetic oxytocin is the most commonly used means 
of inducing labor. However, the inappropriate use of 
certain drugs, called high-risk drugs, can cause signifi-
cant damage to the patient.1 Consequently, the USA-
based Institute for Safe Medication Practices placed the 
intravenous use of oxytocin in a ‘high-risk category’ in 
2007.2
While stimulating labor, the use of oxytocin could 
lead to contraindications associated with uterine, mater-
nal, and fetal causes. Prior to labor induction, risk and 
favor–disfavor assessment must be fully undertaken for 
both the mother and the baby; inducing labor may cause 
undesirable consequences and outcomes both for the 
mother and the baby.1 Synthetic oxytocin can be used 
to intensify or induce labor pain and to prevent postpar-
tum bleeding. Despite its certain capacity to save lives, 
synthetic oxytocin simultaneously involves risks and 
can cause significant harm to the mother and the baby 
if used incorrectly. Although it is common knowledge 
that the use of synthetic oxytocin facilitates labor, it can 
also reduce the amount of oxytocin in women’s body, 
consequently desensitizing the patient against their own 
oxytocin.2
The correlation between oxytocin and hyperstimu-
lation, fetal distress, and adverse neonatal consequences 
is known well. Indeed, in the case of uterine hyperactiv-
ity, reparative disruptions resulting from contractions 
can lead to adverse perinatal consequences related to 
fetal hypoxia.3, 4 Reducing the amount of synthetic 
oxytocin during labor is important for analyzing and as-
sessing dystocia management practices.4, 5 Risks posed 
to the fetus due to oxytocin use means that careful man-
agement and safe use and application of oxytocin are 
vital.5 Improper oxytocin use during labor is dangerous 
both for the mother and the baby.6 Early or late use 
can be related to the progress of labor dystocia. Labor 
dystocia is one of the main causes of increased maternal 
morbidity and operative delivery.7
Synthetic oxytocin is a commonly used drug 
during delivery and after birth.1 For this reason, the 
mechanism of action and side effects should be known 
well by healthcare professionals. Some studies evalu-
ated the effects of synthetic oxytocin, which is widely 
used in our country for inducing labor, on maternal and 
neonatal health in the postpartum period. In studies 
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conducted, it is stated that synthetic oxytocin used dur-
ing labor may cause complications such as disruption of 
the natural oxytocin system in the mother, postpartum 
hemorrhage, depression, and breastfeeding difficulties. 
In addition, it has been stated that hyperbilirubinemia 
can be seen in the newborn, and suction problems may 
occur as a result of the effects on reflexes associated 
with sucking.3, 4, 8 The World Health Organization does 
not recommend routine use of oxytocin to speed up 
delivery in the intrapartum care guide for positive deliv-
ery experience.9 When the literature is examined, there 
are a few studies in the world about the use of oxytocin 
during labor.10–12 In the qualitative study of Deepak and 
others involving 140 health workers and community 
members in India, the current knowledge, attitudes, and 
practices of the participants on the use of uterotonic in 
labor and delivery were evaluated.10 In the qualitative 
study conducted by Oliver et al., which included 158 
healthcare providers (pharmacists, midwives, nurses, 
doctors, and obstetricians) and 40 key informants (supply 
chain experts, program managers, and policy-makers), 
the perspectives and practices of the participants about 
oxytocin use, storage conditions and preventing fac-
tors and quality were evaluated.11 Another study was 
conducted in Lagos State, Nigeria, to assess clinical 
experiences with the quality of oxytocin used by health-
care providers.12 In Turkey, only one study was found to 
have evaluated the use of oxytocin by healthcare profes-
sionals for the use of synthetic oxytocin.13 This study 
is important and valuable due to the limited number of 
studies in the literature. This descriptive study aims to 
explore the use of oxytocin by healthcare professionals 
during labor.
MATERIALS AND METHODS
Research population and sample
The research population for this study includes all 
healthcare professionals (doctors, midwives, nurses) 
working at the delivery room of a medical faculty 
hospital, a training and research hospital, a maternal 
hospital, and a private hospital in Adana, southern 
Turkey. A total of 132 healthcare professionals work in 
these hospitals. OpenEpi, version 3, statistical software 
was used to calculate the sample size. The sample 
size was calculated with 95% confidence interval, 5% 
margin of error, which indicated the population of 80%, 
at least 99 health professionals to represent (power) the 
population.14 This study’s sample group consists of 107 
healthcare professionals; this included all healthcare 
professionals who had worked in the aforementioned 
hospitals between 1st and 30th May 2017 and who agreed 
to participate in the study on a voluntary basis. Overall, 
81% of the research population was reached.
Data collection forms
The study data were gathered using a survey form. This 
survey form was developed in line with the existing 
literature studies.7, 13, 15–19
The survey was comprised of 30 questions; seven 
questions concern socio-demographical information of 
participants, while 23 questions concern the knowledge 
(5) and actual use (17) of oxytocin by healthcare profes-
sionals and a participant’s views.
Additionally, in the questionnaire, possible 
mistakes that healthcare professionals may encounter 
regarding oxytocin administration were asked based on 
the principles of drug administration. The participants 
were asked to rate the frequency of encountering 
these mistakes as “Never, Sometimes, Usually.” The 
principles of drug administration: The right patient, the 
right medicine, the right effect, the right dose, the right 
route, the right medicine form, the right time, the right 
record.17 In addition, the participants were asked to 
score between 0 and 10, with the degree of finding the 
important mistakes encountered as “0 = Insignificant, 
10 = Very important.”
The data were collected by the researchers from 
the participants based on the self-report method. The 
questions in the content of the survey were basically 
multiple choice, with some requiring yes/no answers or 
answers accordingly on scales. Only the question about 
the views of the participants was open-ended. The ques-
tions left blank in the questionnaire were not analyzed.
Statistical analyses
The participants’ responses on socio-demographic 
information and oxytocin use were analyzed using 
descriptive statistics (numbers, percentages, and average 
analyses) in the Statistical Package for Social Sciences 
(SPSS) 20.0 program (IBM, Armonk, NY).
Ethical aspects of the study
Approval to conduct this study was received from 
Cukurova University, Faculty of Medicine Ethics 
Committee (Date: 7.4.2017; Permission no: 2017/76/30). 
All information and data used in this study were col-
lected from the participants on a voluntary basis and 
according to the participants’ consent.
RESULTS
The average age of the participants was 36.76 ± 8.70 (min: 
21, max: 64) years, the total working experience was 
14.43 ± 8.80 (min: 1, max: 37) years, and the working 
experience in the delivery room was 7.79 ± 7.73 (min: 
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0–1, max: 34) years. Furthermore, 87.6% were females, 
73.8% were midwives, 62.6% were graduates of a 
Healthcare Sciences Faculty/Healthcare Collage, and 
43% worked in a maternity hospital. (Table 1).
The study revealed that 85.6% (n = 97) of the 
participants knew that contractions were an effect of 
oxytocin use; 57.9% (n = 95) knew that fetal distress 
was a possible side effect of oxytocin; and 64.7% (n 
= 17) knew that oxytocin interacted with uterotonics. 
Additionally, 98.1% (n = 103) reportedly knew the cor-
rect storage conditions of oxytocin, and 49.4% (n = 83) 
knew that oxytocin should be stored at 2–8°C (Table 2).
The distribution of the data on the participants’ use 
of oxytocin is presented in Table 3. Overall, 69.2% (n = 
104) of the participants stated that they applied oxytocin 
as a fluid; of these, 47% (n = 100) responded that they 
applied it in a fluid of 5% Dextrose. Furthermore, 90.3% 
(n = 103) of participants responded that they applied 
oxytocin according to a doctor’s request, while 30% (n 
= 80) of participants said that they paid attention to in-
fusion speed and duration when preparing and applying 
oxytocin. A total of 26.3% (n = 80) of the participants 
responded that they paid attention to oxytocin dose 
while 26.3% (n = 80) said that they tracked oxytocin 
use with non-stress test and fetal monitoring; 94.2% (n 
= 103) responded that they paid attention to the expiry 
date of the oxytocin they applied. Overall, 90.7% (n = 
107) of participants responded that they did not make 
mistakes while applying oxytocin while 32.7% (n = 107) 
responded that they had encountered mistakes during 
the application; 40.4% (n = 99) said that they notified 
the relevant individual when such mistakes are expe-
rienced. Concerning the parameters to be considered 
while preparing and applying oxytocin, the participants’ 
responses revealed that they were aware of either four, 
three, or two principles of drug administration. As each 
participant who knew the principles of drug administra-
tion stated a different principle, the principles were 
given as numbers.
Concerning the mistakes encountered about 
the drug administration, the participants’ responses 
revealed they did not encounter any mistakes about the 
application and use of oxytocin. Overall, 40% of the 
participants responded that they sometimes forgot to 
administer the medication, 39.2% responded that they 
sometimes forgot to register the medication, 33.3% of 
Table 1. Participants' socio-demographic information
Socio-demographic aspects n %
Age (years) (Mean ± SD = 36.76 ± 8.70) (min: 21, max: 64)
Total working experience (years) (Mean ± SD = 14.43 ± 8.80) (min: 1, max: 37)
Working experience in delivery room (years) (Mean ± SD = 7.79 ± 7.73) (min:0–1, max: 34)
Sex
 Male 13 12.1
 Female 94 87.9
Profession
 Doctor 23 21.5
 Midwife 79 73.8
 Nurse 5 4.7
Graduated from
 Medical faculty 23 21.5
 Faculty of health sciences/Health collage 67 62.6
 Healthcare high school 9 8.4
 Other 8 7.5
Workplace
 Maternity hospital 46 43.0
 Medical faculty hospital 10 9.3
 Private hospital 14 13.1
 Training and research hospital 23 21.5
Total 107 100
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participants responded that they sometimes application 
to wrong speed and 31.4% of participants responded 
that they sometimes not observing the effect of the drug. 
31% of participants responded that they sometimes ap-
plication to wrong dose, 30.1% of participants responded 
that they sometimes application to wrong time, 18.6% of 
participants responded that they sometimes application 
to wrong method, 17.5% of participants responded that 
they sometimes application to wrong drug and 12.9% of 
participants responded that they sometimes application 
to wrong patient (Table 4).
When the participant’s responses regarding the use 
Table 2. Percentage of participants with knowledge about the use of oxytocin
Data n %
*Possible effects of oxytocin (n† = 97)
 Contraction 83 85.6
 Controls postpartum bleeding 18 18.6
 Dilatation and effacement 11 11.3
 Ensures milk flow/lactation 9 9.3
 Accelerates labor 9 9.3
 Supports uterus after labor 7 7.2
 Other 12 12.3
*Possible side effects of oxytocin (n† = 95)
 Fetal distress 55 57.9
 Rupture 39 41.1
 Tetanic contractions 28 29.5
 Tachycardia/bradycardia 16 16.8
 Fluid retention 9 9.5
 Hypotension/hypertension 7 7.4
 Atonia 5 5.3
 Lacerations 4 4.2
 Other 17 18.2
*Drug interaction (n† = 17)
 Uterotonics 11 64.7
 Magnesium sulphate 4 23.5
 Narcotics 2 11.8
 Analgesics 2 11.8
 Other 3 17.7
Do you have information on storage conditions of oxytocin? (n†= 103)
 Yes 101 98.1
 No 2 1.9
*Storage condition‡ (n† = 83)
 2–8°C 41 49.4
 Refrigerator 15 18.1
 4°C 11 13.3
 Cold chain 9 10.8
 Protection against heat and light 8 9.6
 Other 9 10.8
*Participants provided more than one choice. †Only participants who answered the questions. ‡Storage conditions are based on the 
instruction manual for the use of Synpitan Forte (Deva Holding, Istanbul, Turkey).19
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Table 3. Distribution of data on participants' usage and error experience when applying oxytocin
Oxytocin application n %
Oxytocin application methods (n† = 104)
 In fluid 72 69.2
 Fluid + IM 17 16.3
 Fluid + IV push + IM 9 8.7
 Fluid + IV push 6 5.8
Decision on using oxytocin (n† = 103)
 Doctor’s request 93 90.3
 Doctor’s request + Hospital protocol 3 2.9
 Doctor’s request + Hospital protocol + My personal decision 3 2.9
 Doctor’s request + Routinely on each labor 2 1.9
 Doctor’s request + My personal decision 1 1.0
 Hospital protocol 1 1.0
Frequently used fluids while applying oxytocin (n† = 100)
 5% Dextrose 47 47.0
 Normal saline 16 16.0
 Ringer lactate 15 15.0
 5% dextrose + NS 10 10.0
 5% dextrose + RL 9 9.0
 Other (NS + RL, 5% dextrose + NS + RL, all fluids) 3 3.0
*Parameters taken into consideration while preparing and applying oxytocin (n† = 80)
 Infusion speed and duration 24 30.0
 Non-stress test and fetal monitoring 21 26.3
 Dose 21 26.3
 Storage conditions 14 17.5
 Doctor’s request 12 15.0
 Three of the principles of drug administration‡ 11 13.8
 Four of the principles of drug administration‡ 9 11.3
 Application mean and method 8 10.0
 The vital signs of the patients§ 7 8.8
 Two of the principles of drug administration‡ 7 8.8
 Other 13 17.7
Tracking oxytocin’s date of expiry (n† = 103)
 Yes 97 94.2
 No 6 5.8
Making an error while applying oxytocin (n = 107)
 Yes 10 9.3
 No 97 90.7
Encountering an error while applying oxytocin (n = 107)
 Yes 35 32.7
 No 72 67.3
Notifying about drug errors related to oxytocin (n† = 99)
 Yes 40 40.4
 No 59 59.6
*Participants provided more than one choice. †Only participants who answered the questions. ‡Number of principles that they know 
correctly from the principles of drug administration (the right patient, the right medicine, the right effect, the right dose, the right route, 
the right medicine form, the right time, the right record). §Body temperature, pulse rate, respiration rate, blood pressure of patient. IM, 
intramuscular; IV, intravenous; NS, normal saline; RL, ringer lactate.
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of oxytocin use were examined, the data revealed that 
58.8% responded with “regular use of oxytocin must 
be avoided”; 33.3% responded “intervention-free labors 
must be increased”; 16,7% responded that “healthcare 
staff must be trained”; 16.7% mentioned that “frequent 
follow-ups must be performed”; and, 8.3% responded 
that “[an] infusion pump must be used during oxytocin 
practice” (n = 12) (Table 5).
DISCUSSION
This descriptive study aimed to evaluate the use of 
oxytocin by healthcare professionals during labor. It was 
conducted with the participation of 107 health profes-
sionals working in medical centers in Adana, Turkey. 
Synthetic oxytocin is among the most common means 
of inducing labor in Turkey. Natural oxytocin synthe-
sized in the hypothalamus during vaginal delivery has 
a uterotonic effect by increasing uterine contractions. 
Synthetic oxytocin induction is physiologically similar 
to that of normal labor. Intravenous oxytocin response 
is observed within 3–5 minutes and plasma reaches 
a steady state after 40 minutes.20 Only one study in 
Turkey was found to have evaluated the healthcare 
professionals’ use of oxytocin and the difficulties they 
encountered.13 It is highly important for physicians, 
midwives, and nurses to be sensitive and knowledgeable 
about the use of oxytocin during labor, as well as the 
related complications that may affect fetal and maternal 
health during oxytocin administration.
This study examines the knowledge level of the 
participants regarding the use of oxytocin. The data 
were collected from healthcare professionals, which 
revealed that most of the health workers knew or were 
aware of the stimulating effect of oxytocin regarding 
uterine contractions, the most important effect of oxy-
tocin. Furthermore, the study data revealed that more 
than half of the healthcare professionals were aware that 
oxytocin could cause fetal distress.
Although the majority of the participants stated that 
they knew the correct storage conditions for oxytocin, 
it was found that more than half of the correct storage 
conditions could not be answered. In the study of Oliver 
Table 4. Frequency of errors encountered by participants concerning oxytocin use
Errors encountered Occurrence frequency Scores given by partici-
pants for errors according 
to their importance (on a 
scale of 1–10)
Never Sometimes Usually Mean ± SD
n % n % n %
Wrong drug (n = 103) 85 82.5 18 17.5 – – 9.75 ± 1.23
Wrong dose (n = 103) 70 68.0 32 31.0 1 1.0 9.49 ± 1.50
Wrong method (n = 102) 83 81.4 19 18.6 – – 9.54 ± 1.74
Wrong time (n = 103) 66 64.1 31 30.1 6 5.8 9.03 ± 2.01
Wrong speed (n = 102) 63 61.8 34 33.3 5 4.9 9.37 ± 1.72
Wrong patient (n = 101) 87 86.1 13 12.9 1 1.0 9.72 ± 1.21
Forgetting to administer the drug (n = 100) 60 60.0 40 40.0 – – 9.07 ± 2.03
Not registering the drug (n = 102) 60 58.8 40 39.2 2 2.0 9.22 ± 1.87
Not observing the effect of the drug (n = 102) 65 63.7 32 31.4 5 4.9 9.46 ± 1.63
Table 5. Breakdown of participants' views on oxytocin application during labor
Participants’ views (n = 12) n %
Regular use of oxytocin must be avoided 7 58.8
Intervention-free labors must be increased 4 33.3
Healthcare staff must be trained 2 16.7
Frequent follow-up 2 16.7
Infusion pump must be used during oxytocin practice 1 8.3
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et al., it was reported that stakeholder awareness of 
oxytocin heat sensitivity and the requirement for cold 
storage of the drug was widespread in Ethiopia but more 
limited in Myanmar and India.11 In line with the results 
of the present study, the study conducted by Ejekam et 
al. reported that approximately half of the participants 
and Deepak et al. stated that most of their participants 
did not know the storage conditions of oxytocin.10, 12 
The results showed that healthcare professionals did not 
have enough knowledge about the storage of oxytocin.
When health workers’ oxytocin applications 
were evaluated, it was determined that the majority 
of healthcare workers knew that oxytocin should be 
given in 5% Dextrose solution, in accordance with doc-
tors’ orders, and administered within the expiry date. 
However, it was determined that health workers did not 
have enough knowledge about monitoring the oxytocin 
dose, infusion rate, duration, and non-stress test, as well 
as fetal monitorization, which are important during 
administration. Additionally, it was found that the par-
ticipants could not answer the eight principles of drug 
administration that are important for drug safety during 
the preparation and administration of oxytocin. Deepak 
et al. stated both health providers and chemists appeared 
to have incomplete and inconsistent knowledge about 
uterotonics, including appropriate dosage and required 
monitoring.10 The results of the present study is parallel 
with Deepak et al.’s study.
Synthetic oxytocin is widely used in a number 
of countries; indeed, it is used in more than half of all 
cases of labor. There is no standard protocol published 
by the Ministry of Health to initiate oxytocin induc-
tion during the labor in Turkey. Written protocols of 
each hospital are prepared by their own institutions in 
accordance with current clinical evidence and updated 
when necessary. In addition, the oxytocin application 
protocols differ in hospitals. Although no data exists 
concerning the frequency of oxytocin use in clinical 
birth cases in Turkey, induction through oxytocin is 
frequently used to initiate labor.13, 20 It is important 
to remember that midwives and nurses are the health 
professionals who follow both the mother and the fetus 
during labor and therefore are likely to be the first ones 
to determine or detect the development of a negative 
situation or outcome. The role of health personnel 
regarding oxytocin use is vital for protecting the fetus 
and maintaining maternal health. This study showed 
that health professionals’ competence about the use of 
oxytocin was at the knowledge level; there is a need for 
forming protocol for the use of oxytocin use.
Improper drug or medication use are among the 
most common medical mistakes; such mistakes might 
include an incorrect drug choice, dosage, option, or 
technique by the health professional administering 
drugs.15 Every drug mistake that harms the safety and 
health of a patient creates additional costs for both health 
services and institutions. The majority of drug mistakes 
can be prevented without harming the patient. A total 
of 18 drugs are identified in the high-risk category of 
drugs, with synthetic oxytocin also being included in 
the first 12 ‘high-risk’ items.21 Incorrect use of oxytocin 
may cause damage to the mother and her fetus. Nearly 
one-third of the health professionals participating in the 
study reported that mistakes were made regarding their 
administration of oxytocin, while more than half did not 
report making a mistake. In this study, health profes-
sionals are expected to be more sensitive about mistakes 
during oxytocin administration to protect the fetus and 
maternal health.
More than half the participants of this study who 
shared their opinions regarding oxytocin use during 
labor indicated that they avoided routine oxytocin use, 
and about one-third responded that they thought the 
number of non-invasive labors should increase. In the 
study conducted by Demirci, et al. (2005), 16% of physi-
cians that they had used oxytocin to accelerate normal 
labor.13 The rate and prevalence of complications within 
pregnancies involving synthetic oxytocin use are higher 
than those of natural pregnancies.22 Oxytocin increases 
the duration and severity of uterine contractions and 
can lead to uteroplacental perfusion and fetal distress. 
Consequently, the administration of oxytocin should 
not be performed routinely; rather, it should be applied 
cautiously, carefully, and only when needed.23 Today, 
the basic approach to pregnancy and labor is that it is a 
physiological process that demands minimal medical 
intervention. Natural childbirth without intervention 
is undertaken as much as possible.24 In their study that 
investigated the opinions of nurses, midwives, and 
physicians concerning mother-friendly labor practices, 
Olgaç and Karaçam (2017) found that 70.5% of their 
study participants agreed with the opinion that routine 
induction should not be performed during labor.25 In our 
study, the opinions of health professionals supporting 
natural birth are also satisfactory.
In conclusion, it was determined that most of the 
participants answered the questions about the effect of 
oxytocin correctly, but they could not respond to all the 
side effects of oxytocin. It was found that most of the 
participants were not able to answer questions related 
to the interaction of oxytocin with other medicines 
correctly; they also could not answer the storage condi-
tions that are important for the effectiveness of the drug 
correctly. In addition, the importance level given to the 
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principles of drug administration by the participants 
was generally found to be high.
In this regard, the correct use of oxytocin, a high-
risk and frequently-used drug in obstetrics should be 
known by all healthcare professionals. It is thought that 
the results obtained from this study conducted to evalu-
ate the use of oxytocin during delivery by healthcare 
professionals working in delivery rooms will increase 
the awareness of healthcare professionals about the 
importance of oxytocin use at labor. It is recommended 
that health professionals be given in-service trainings 
that are repeated within the scope of medicine and 
patient safety in line with special medicines for the unit 
they work with.
LIMITATIONS OF THE RESEARCH
This study has some limitations. The participants did 
not answer some questions. Since the questions were 
answered by the self-report method, no interventions 
were performed for the questions that remained unan-
swered. Therefore, only the questions answered by the 
participants were evaluated. In addition, these results 
of the study are valid for the sample group in Adana, 
Turkey. Therefore, they can not be generalized.
The authors declare no conflict of interest.
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